Clinical Utilization Management Guidelines
Customize your policy alerts
Sign up for Highmark Blue Cross Blue Shield Wny Policy ADMIN.00004 alerts
Get alerted when Policy ADMIN.00004 changes without checking for updates manually.
Monitor payer policy activity
Lists the Clinical Utilization Management Guidelines adopted for Highmark Medicaid Managed Care, Health and Recovery Plan, Child Health Plus, and Essential Plan members, including applicable criteria sources and medical-necessity review processes.
Numerous Clinical Utilization Management Guidelines were adopted as new items for Medicaid members.
CG-SURG-131, Transcatheter Aortic Heart Valve Procedures, was identified as a new guideline.
CG-SURG-132, Transendoscopic Therapy for Gastroesophageal Reflux Disease, Dysphagia, or Gastroparesis, was identified as a new guideline.
CG-SURG-133, Intraluminal Left Atrial Appendage Closure Devices, was identified as a new guideline.
CG-TRANS-04, Umbilical Cord Blood Progenitor Cell Collection, Storage, and Transplantation, was identified as a new guideline.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.